Recent Press Releases

NeuroPhage Discovers GAIM-changing Molecules to Combat Alzheimer's Disease and Other Neurodegenerative Disorders

Cambridge, MA, April 22, 2014 – Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are...

Cancer Stem Cells Linked to Drug Resistance

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine...

Ginseng Can Treat and Prevent Influenza and RSV

Newswise — ATLANTA--Ginseng can help treat and prevent influenza and respiratory syncytial virus (RSV), a respiratory virus that infects the lungs and breathing passages, according to research...

Re-Emergence of Ebola Focuses Need for Global Surveillance Strategies

NEW YORK - April 17, 2014 - EcoHealth Alliance, a nonprofit organization that focuses on conservation and global public health issues, published a comprehensive review today examining the current...

Scripps Florida Scientists Awarded $2 Million to Study Improvements in Anti-Diabetic Drug Design

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer and more...

'Chaperone' compounds offer new approach to Alzheimer's treatment

NEW YORK, NY (April 20, 2014) — A team of researchers from Columbia University Medical Center (CUMC), Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to...

Dengue Mosquito Population Reduced by 79% in Jacobina, Bahia, Using Oxitec Solution

A project taking place in Jacobina, Bahia has again shown the effectiveness of the Oxitec OX513A mosquito in reducing the dengue mosquito population. Led by the social organisation Moscamed, the...

3D printing cancer cells to mimic tumours

A group of researchers in China and the US have successfully created a 3D model of a cancerous tumour using a 3D printer. The model, which consists of a scaffold of fibrous proteins coated in...

How a Silly Putty ingredient could advance stem cell therapies

ANN ARBOR—The sponginess of the environment where human embryonic stem cells are growing affects the type of specialized cells they eventually become, a University of Michigan study shows. The...

New vaccine hope for leading viral cause of birth defects

Experts in infection and immunity have made a path-finding discovery that could lead to the development of a vaccine for a health-ravaging virus that affects around 50% of adults in the UK....

A Bad Penny: Cancer's Thirst For Copper Can Be Targeted

DURHAM, N.C. – Drugs used to block copper absorption for a rare genetic condition may find an additional use as a treatment for certain types of cancer, researchers at Duke Medicine report. The...

Study Shows Cellceutix Antibiotic Active Against Drug-Resistant Superbug Klebsiella Pneumoniae

BEVERLY, MA–(Marketwired – Apr 14, 2014) – Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies...

Living organ regenerated for first time: Thymus rebuilt in mice

A team of scientists at the University of Edinburgh has succeeded in regenerating a living organ for the first time. The team rebuilt the thymus -- an organ in the body located next to the heart that...

Halozyme Announces Preclinical Data Presentations At The Association Of Cancer Research Annual Meeting

SAN DIEGO, April 8, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that two scientific poster presentations on the pharmacology of PEGPH20 will be made at the...

Scientists reveal potential link between brain development and breast cancer gene

LA JOLLA----Scientists at the Salk Institute have uncovered details into a surprising----and crucial----link between brain development and a gene whose mutation is tied to breast and ovarian cancer....

DelMar Pharmaceuticals Presents Promising Pre-clinical Data with VAL-083 in Lung Cancer

VANCOUVER, British Columbia, MENLO PARK, Calif. and SAN DIEGO, April 7, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc.(OTCQB: DMPI) ("DelMar") today announced the presentation of new...

EMD Serono Enters into Research Agreement with Pfizer and Broad Institute

ROCKLAND, Mass., April 1, 2014 /PRNewswire/ -- EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, today announced they have signed a research agreement with Pfizer Inc. and the Broad...

Caffeine against Alzheimer's disease? Positive effect on tau deposits demonstrated

As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the University of Lille was able to demonstrate for the...

LIEBER INSTITUTE ANNOUNCES CONSORTIUM TO IDENTIFY HOW GENES BUILD A BRAIN WITH THE GOAL OF DEVELOPING TREATMENTS FOR BRAIN DISORDERS

The Lieber Institute for Brain Development (LIBD) and pharmaceutical companies Astellas, Eli Lilly and Company, Lundbeck, Pfizer Inc. and Roche are participating in an early-stage research consortium...

Daiichi Sankyo and UCSF Announce Collaboration in Drug Discovery Research for Neurodegenerative Diseases

Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo) and UC San Francisco (UCSF) announced today that they have established a drug-discovery collaboration focused on developing novel therapeutics and...